FDA — authorised 20 November 2001
- Status: approved
🇺🇸 Ortho Evra in United States
FDA authorised Ortho Evra on 20 November 2001
Marketing authorisations
FDA — authorised 20 November 2001
- Application: NDA021180
- Marketing authorisation holder: JANSSEN PHARMS
- Local brand name: ORTHO EVRA
- Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
- Status: approved
Ortho Evra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Ortho Evra approved in United States?
Yes. FDA authorised it on 20 November 2001; FDA authorised it on 20 November 2001.
Who is the marketing authorisation holder for Ortho Evra in United States?
Marketing authorisation holder not available in our data.